Summary
Advances in MR imaging techniques have made considerable progress in recent years. Both high resolution anatomical imaging and functional parameters when using higher advanced MR techniques have become a valuable adjunct to conventional imaging, helping to further differentiate a lesion or to better determine an adequate therapy or biopsy site. Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI) are available on virtually every MR scanner, although especially for DTI the post processing is somewhat more demanding. The use of MR perfusion and MR spectroscopy (MRS) has become more and more routine. BOLD imaging (fMRI) is able to correlate brain activation with specific tasks (paradigms), which have also added information for presurgical evaluation of brain metastases or brain tumour in general.
Similar content being viewed by others
References
Essig M, Giesel F, Stieltjes B, Weber MA. Functional imaging for brain tumours (perfusion, DTI and MR spectroscopy). Radiologe, 47: 513–519, 2007
Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Am J Neuroradiol, 28: 1078–1084, 2007
Stippich C, Rapps N, Dreyhaupt J, Durst A, Kress B, Nennig E, Tronnier VM, Sartor K. Localizing and lateralizing language in patients with brain tumours: feasibility of routine preoperative functional MR imaging in 81 consecutive patients. Radiology, 243: 828–836, 2007
Krautmacher C, Willinek WA, Tschampa HJ, Born M, Träber F, Gieseke J, Textor HJ, Schild HH, Kuhl CK. Brain tumours: full- and half-dose contrast-enhanced MR imaging at 3.0 T-compared with 1.5 T-Initial Experience. Radiology, 237: 1014–1019, 2005
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gotwald, T. Imaging of brain tumours with special emphasis on metastatic disease. memo 1 (Suppl 2), 7–10 (2008). https://doi.org/10.1007/s12254-008-0024-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12254-008-0024-3